CN Patent
CN111417433B — 从心室植入的无引线心脏起搏器检测心室充盈期间心房收缩定时基准的方法和系统
Assigned to Cardiac Pacemakers Inc · Expires 2024-04-30 · 2y expired
What this patent protects
本发明公开了一种可植入心室的医疗设备,其包括感测模块,所述感测模块被配置为在心室充盈期间检测伪影并至少部分基于所检测到的伪影来识别心房事件。所述可植入医疗设备中的控制电路配置为向患者心脏递送心室起搏治疗,其中所述心室起搏治疗的时间至少部分取决于所识别的心房事件。
USPTO Abstract
本发明公开了一种可植入心室的医疗设备,其包括感测模块,所述感测模块被配置为在心室充盈期间检测伪影并至少部分基于所检测到的伪影来识别心房事件。所述可植入医疗设备中的控制电路配置为向患者心脏递送心室起搏治疗,其中所述心室起搏治疗的时间至少部分取决于所识别的心房事件。
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.